Showing 621-630 of 1562 results for "".
JAMA: Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies
https://reachmd.com/programs/Audioabstracts/jama-noninvasive-prenatal-testing-and-incidental-detection-occult-maternal-malignancies/7628/Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies Diana W. Bianchi, MD; Darya Chudova, PhD; Amy J. Sehnert, MD; Sucheta Bhatt, MD; Kathryn Murray, MS; Tracy L. Prosen, MD; Judy E. Garber, MD; Louise Wilkins-Haug, MD, PhD; Neeta L. Vora, MD; Stephen Warsof, MD; JamAdvances in the Management of Moderate-to-Severe Atopic Dermatitis
https://reachmd.com/programs/cme/advances-in-the-management-of-moderate-to-severe-atopic-dermatitis/10967/This multidisciplinary faculty panel and a patient deliberate over challenging topics in moderate-to-severe atopic dermatitis.Targeting PIK3CA Mutations in HR+/HER2- Breast Cancer: New Insights from ReDiscover
https://reachmd.com/programs/medical-industry-feature/targeting-pik3ca-mutations-in-hrher2-breast-cancer-new-insights-from-rediscover/35475/About 40 percent of patients with metastatic HR+/HER2- breast cancer have an activating mutation in the PIK3CA gene,1,2 which plays a key role not only in tumor growth, but also in driving resistance to endocrine therapy.3-5 And while there are several FDA-approved PI3K pathway-targeted agents for pProtecting the Vulnerable from COVID-19: A Street Physician’s Perspective
https://reachmd.com/programs/covid-19-frontlines/protecting-the-vulnerable-from-covid-19-a-street-physicians-perspective/11450/Most Americans are staying home to help control the COVID-19 pandemic, but what happens when a home is made up of cardboard boxes on the street?RAI-R DTC: Explore This Pivotal Study Data
https://reachmd.com/programs/medical-industry-feature/rai-r-dtc-explore-this-pivotal-study-data/35516/The SELECT study, a phase III multicenter, randomized, double-blind, placebo-controlled trial, evaluated the treatment option LENVIMA® (lenvatinib) in patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer. Tune in to hear Dr. Mark LupKOL KNOCKOUTTM OCULOPLASTICS EDITION 8 Cases of Tailored Treatment for Thyroid Eye Disease
https://evolvemeded.com/specialty/cataract-refractive/kol-knockout-oculoplastics-8-cases-of-tailored-treatment-for-thyroid-eye-disease/32750/Content Source This continuing medical education (CME) activity captures content from two live-virtual symposia and one in-person symposium. Activity Description This supplement summarizes a discussion on thyroid eye disease (TED), including clinical findings, laboratory findings, medical and surA Treatment for Acute Manic or Mixed Episodes of Bipolar I Disorder in Adults
https://reachmd.com/industry-feature/psychiatry-and-mental-health/treatment-acute-manic-mixed-episodes-bipolar-I-disorder-adults/7534/Please see Important Safety Information, including Boxed Warning. Host Dr. Matt Birnholz welcomes Dr. Roger McIntyre...A Treatment for Schizophrenia in Adults
https://reachmd.com/industry-feature/psychiatry-and-mental-health/treatment-schizophrenia-adults/7535/Please see Important Safety Information, including Boxed Warning.Host Dr. Matt Birnholz and guest expert, Dr. Roger McIntyre...Clinical Exchanges®: Optimizing Management of Nontuberculous Mycobacteria Lung Disease
https://reachmd.com/programs/cme/clinical-exchanges-optimizing-management-of-nontuberculous-mycobacteria-lung-disease/11060/Explore the initial and ongoing management of nontuberculous mycobacteria lung disease through the use of shared decision making.From Risk to Resilience: Best Practices for Improving Outcomes in Early-Stage ER+/HER2- Breast Cancer
https://reachmd.com/programs/cme/from-risk-to-resilience-best-practices-for-improving-outcomes-in-early-stage-erher2-breast-cancer/32681/Learn about the importance of risk assessment, the role of CDK4/6 inhibitors, and the management of treatment-emergent toxicities in the treatment of HR+, HER2- early breast cancer.